09/04/2024 6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/21/2024 6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/09/2024 6:27 PM | Axsome Therapeutics (Issuer) Jacobson Mark L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/05/2024 6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/11/2024 3:30 PM | Axsome Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/11/2024 3:30 PM | Axsome Therapeutics (Issuer) Saad Mark E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 3:31 PM | Axsome Therapeutics (Issuer) JEFFS ROGER (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/11/2024 3:31 PM | Axsome Therapeutics (Issuer) Coleman Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 3:32 PM | Axsome Therapeutics (Issuer) Mahony Susan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 6:38 AM | Axsome Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/29/2024 7:11 PM | Axsome Therapeutics (Issuer) Axsome Therapeutics (Issuer) Coleman Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 7:12 PM | Axsome Therapeutics (Issuer) Axsome Therapeutics (Issuer) Jacobson Mark L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:28 PM | Axsome Therapeutics (Subject) Coleman Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/06/2024 4:20 PM | Axsome Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024 6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2024 5:46 PM | Axsome Therapeutics (Issuer) Jacobson Mark L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 5:14 PM | Axsome Therapeutics (Subject) Jacobson Mark L. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024 7:27 AM | Axsome Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/25/2024 8:02 AM | Axsome Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/25/2024 8:06 AM | Axsome Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/19/2024 6:06 AM | Axsome Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/15/2024 7:05 PM | Axsome Therapeutics (Issuer) JEFFS ROGER (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 6:09 PM | Axsome Therapeutics (Subject) JEFFS ROGER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 5:25 PM | Axsome Therapeutics (Issuer) Pizzie Nick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 5:34 PM | Axsome Therapeutics (Issuer) Jacobson Mark L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 5:34 PM | Axsome Therapeutics (Issuer) Saad Mark E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 5:34 PM | Axsome Therapeutics (Issuer) JEFFS ROGER (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 5:18 PM | Axsome Therapeutics (Issuer) Mahony Susan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 5:20 PM | Axsome Therapeutics (Issuer) TABUTEAU HERRIOT (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:39 PM | Axsome Therapeutics (Issuer) Murdock Hunter R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 7:10 AM | Axsome Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/20/2024 6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 2:46 PM | Axsome Therapeutics (Subject) Fairmount Funds Management LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 6:26 AM | Axsome Therapeutics (Subject) RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
01/08/2024 6:10 AM | Axsome Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 6:11 AM | Axsome Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2023 3:39 PM | Axsome Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023 6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/12/2023 7:30 PM | Axsome Therapeutics (Issuer) Mahony Susan (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/12/2023 7:33 PM | Axsome Therapeutics (Issuer) Mahony Susan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/11/2023 4:03 PM | Axsome Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Perfect Crypto Buying Opportunity for 50 Cents (Ad) When cryptos take a hit, the mom and pop investors run for the hills.
But the top investors keep buying with both fists. They know it's only a matter of time before another bull run.
Now, Crypto Insiders Are Scooping up Lesser-Known Coins and Making Serious Bank![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9464&Placement=NativeDisplay&Source=NativeDisplay) Go here to get full details on this crypto now. |
09/15/2023 5:30 PM | Axsome Therapeutics (Issuer) Coleman Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/15/2023 5:32 PM | Axsome Therapeutics (Subject) Coleman Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |